Holen Sie sich die Stockscreener-App
29.52
0.62%
-0.185
Schlusskurs vom Vortag:
$29.70
Offen:
$29.94
24-Stunden-Volumen:
175.78K
Relative Volume:
0.04
Marktkapitalisierung:
$8.34B
Einnahmen:
$907.29M
Nettoeinkommen (Verlust:
$33.98M
KGV:
-20.14
EPS:
-1.4655
Netto-Cashflow:
$115.75M
1W Leistung:
-2.88%
1M Leistung:
+21.26%
6M Leistung:
+63.52%
1J Leistung:
-3.17%
1-Tages-Spanne:
$29.40
$30.13
1-Wochen-Bereich:
$25.87
$32.56
52-Wochen-Spanne:
$14.19
$33.65
Caris Life Sciences Inc Stock (CAI) Company Profile
Firmenname
Caris Life Sciences Inc
Sektor
Branche
Telefon
(866) 771-8946
Adresse
750 W JOHN CARPENTER FREEWAY, IRVING
Compare CAI vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAI
Caris Life Sciences Inc
|
29.52 | 8.34B | 907.29M | 33.98M | 115.75M | -1.4655 |
VRTX
Vertex Pharmaceuticals Inc
|
511.49 | 129.64B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
220.53 | 88.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
748.76 | 77.09B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
830.71 | 52.24B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
185.50 | 39.76B | 742.00K | -1.37B | -1.07B | -7.0731 |
Caris Life Sciences Inc Stock (CAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-09 | Eingeleitet | UBS | Neutral |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2026-04-13 | Eingeleitet | Jefferies | Buy |
| 2026-04-10 | Eingeleitet | Piper Sandler | Neutral |
| 2026-04-01 | Eingeleitet | Goldman | Buy |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-07-14 | Eingeleitet | BTIG Research | Buy |
| 2025-07-14 | Eingeleitet | BofA Securities | Buy |
| 2025-07-14 | Eingeleitet | Citigroup | Buy |
| 2025-07-14 | Eingeleitet | Evercore ISI | Outperform |
| 2025-07-14 | Eingeleitet | Guggenheim | Buy |
| 2025-07-14 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-14 | Eingeleitet | TD Cowen | Buy |
| 2025-07-14 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-30 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-06-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-09 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-12-09 | Eingeleitet | B. Riley Securities | Buy |
| 2020-10-19 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-06-15 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-05-07 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-08-08 | Bestätigt | Cowen | Outperform |
| 2019-02-21 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2018-10-31 | Bestätigt | Cowen | Outperform |
| 2018-09-28 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-09-07 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2018-04-24 | Eingeleitet | Compass Point | Buy |
| 2018-02-15 | Bestätigt | Cowen | Outperform |
| 2018-02-14 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2017-10-23 | Hochstufung | Cowen | Market Perform → Outperform |
| 2017-07-27 | Bestätigt | Cowen | Market Perform |
| 2017-04-21 | Bestätigt | Cowen | Market Perform |
| 2016-05-04 | Bestätigt | Cowen | Market Perform |
| 2016-02-17 | Bestätigt | Cowen | Market Perform |
| 2016-01-15 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
Alle ansehen
Caris Life Sciences Inc Aktie (CAI) Neueste Nachrichten
Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com Canada
Caris Life Sciences SVP Denton sells $238,626 in shares - Investing.com
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com South Africa
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com India
Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com UK
Insider at Caris Life Sciences (CAI) lines up stock sale - Stock Titan
Caris Life Sciences(CAI.US) Officer Sells US$12.13 Million in Common Stock - Moomoo
Caris Life Sciences vice chairman Brille sells $12.1 million shares By Investing.com - Investing.com UK
Caris Life Sciences (CAI) director plans 400,000-share sale - Stock Titan
Caris Life Sciences vice chairman Brille sells $12.1 million shares - Investing.com
New investor pitch from Caris Life Sciences (CAI) set for Morgan Stanley healthcare event - Stock Titan
UBS Group Upgrades Caris Life Sciences (NASDAQ:CAI) to "Hold" - MarketBeat
Amundi Buys 1,197,392 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Squarepoint Ops LLC Acquires Shares of 380,927 Caris Life Sciences, Inc. $CAI - MarketBeat
Menlo Advisors LLC Acquires Shares of 300,518 Caris Life Sciences, Inc. $CAI - MarketBeat
UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target - marketscreener.com
Caris Life Sciences launches national campaign with Kevin Costner to promote early cancer detection test Caris Detect. - Pluang
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect - PR Newswire
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update? - Yahoo Finance
47,595 Shares in Caris Life Sciences, Inc. $CAI Acquired by The Manufacturers Life Insurance Company - MarketBeat
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference - Yahoo Finance
Bank of New York Mellon Corp Takes Position in Caris Life Sciences, Inc. $CAI - MarketBeat
David Baxley Spetzler Sells 478,000 Shares of Caris Life Sciences (NASDAQ:CAI) Stock - MarketBeat
Insider Selling: Caris Life Sciences (NASDAQ:CAI) President Sells 119,212 Shares of Stock - MarketBeat
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Nigeria
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com South Africa
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Australia
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com India
President Spetzler sells $14.8m in Caris Life Sciences stock - investing.com
President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com
After an $11.9M stock sale, Caris Life Sciences (NYSE: CAI) holder plans another - Stock Titan
President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Canada
Insider at Caris Life Sciences (CAI) lines up 2026 stock sale tied to expiring options - Stock Titan
Braidwell LP Purchases 246,585 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - Morningstar
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - PR Newswire
Moore Capital Management LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Deutsche Bank AG Purchases New Position in Caris Life Sciences, Inc. $CAI - MarketBeat
BlackRock Inc. Acquires New Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Canada Pension Plan Investment Board Purchases Shares of 1,374,952 Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - sahmcapital.com
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - PR Newswire
PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences (NASDAQ:CAI) Trading Down 6.2%What's Next? - marketbeat.com
Bank of America Corp DE Lowers Stake in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Stock Is Up 65% in Three Months, But Its Valuation Multiple Just Got Cheaper. - TIKR.com
Caris Life Sciences (NASDAQ: CAI) trust plans another stock sale - Stock Titan
Mitsubishi UFJ Asset Management Co. Ltd. Invests $1.52 Million in Caris Life Sciences, Inc. $CAI - MarketBeat
Finanzdaten der Caris Life Sciences Inc-Aktie (CAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Caris Life Sciences Inc-Aktie (CAI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JOHN RUSSEL DENTON | Officer |
Sep 22 '26 |
Proposed Sale |
31.82 |
7,500 |
238,626 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Sale |
30.33 |
400,000 |
12,132,080 |
230,303 |
| BRIAN J BRILLE | Officer |
Sep 17 '26 |
Proposed Sale |
30.33 |
400,000 |
12,132,080 |
0 |
| Brille Brian J | See Remarks |
Sep 17 '26 |
Option Exercise |
2.44 |
400,000 |
976,000 |
630,303 |
| DAVID SPETZLER | Officer |
Sep 04 '26 |
Proposed Sale |
24.76 |
119,212 |
2,951,117 |
0 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Option Exercise |
2.44 |
250,000 |
610,000 |
1,302,083 |
| Spetzler David Baxley | President |
Sep 04 '26 |
Sale |
24.76 |
119,212 |
2,951,117 |
1,182,871 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Option Exercise |
2.44 |
1,000,000 |
2,440,000 |
1,530,083 |
| DAVID SPETZLER | Officer |
Sep 03 '26 |
Proposed Sale |
24.86 |
478,000 |
11,882,984 |
0 |
| Spetzler David Baxley | President |
Sep 03 '26 |
Sale |
24.86 |
478,000 |
11,882,990 |
1,052,083 |
0.37%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):